SCHEMBL27129809

SCHEMBL27129809

Cc1cc(C(C)N)c2oc(-c3ccccn3)c(C)c(=O)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 1/20 0.36
▸ PIK3CA P42336 4/20 0.36
▸ PIK3CB P42338 3/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ RAB9A P51151 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ AKT1 P31749 1/20 0.34
▸ AKT2 P31751 1/20 0.34
▸ AKT3 Q9Y243 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26884312 1.00 KCNA3 (0.36) KCNA3PIK3CAPIK3CBPIK3CDPIK3CG
SCHEMBL30889597 0.89 PIK3CA (0.37) KCNA3PIK3CAPIK3CBPIK3CDPIK3CG
SCHEMBL27132457 0.86 PIK3CA (0.39) KCNA3PIK3CARAB9AKDM4EHPGD
SCHEMBL26884436 0.86 PIK3CA (0.39) KCNA3PIK3CARAB9AKDM4EHPGD
SCHEMBL26884763 0.86 PIK3CA (0.34) PIK3CAPIK3CBPIK3CDPIK3CGRAB9A
SCHEMBL27126316 0.86 PIK3CA (0.34) PIK3CAPIK3CBPIK3CDPIK3CGRAB9A
SCHEMBL26662576 0.85 PIK3CA (0.44) PIK3CAPIK3CBPIK3CDPIK3CGAKT1
SCHEMBL26662568 0.85 PIK3CA (0.44) PIK3CAPIK3CBPIK3CDPIK3CGAKT1
SCHEMBL27133044 0.84 PIK3CA (0.35) PIK3CAPIK3CBPIK3CDPIK3CGAKT1
SCHEMBL30742064 0.84 PIK3CA (0.32) PIK3CAPIK3CBPIK3CDPIK3CGAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE LOXO ONCOLOGY, INC. 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018115-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PIK3CA, PIK3R4, PIK3R5 KCNA3 1394/4885PIK3CA 1/4885PIK3CB 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback